Skeletal dysplasia
Gene: GNPTAB
Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal
Phenotypes
Mucolipidosis II alpha/beta, MIM# 252500; MONDO:0009650; Mucolipidosis III alpha/beta, MIM# 252600; MONDO:0018931
Publications
from Genereviews:
ML II is evident at birth. Orthopaedic abnormalities may include thoracic deformity, kyphosis, clubfeet, deformed long bones, and/or dislocation of the hip(s).
All children have cardiac involvement, most commonly thickening and insufficiency of the mitral valve and, less frequently, the aortic valve.
ML IIIα/β becomes evident at about age three years.
Phenotypes intermediate between ML II and ML IIIα/β are characterized by physical growth in infancy that resembles that of ML II and neuromotor and speech development that resemble that of ML IIIα/βCreated: 30 Nov 2021, 12:38 p.m. | Last Modified: 30 Nov 2021, 12:38 p.m.
Panel Version: 0.9952
Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal
Phenotypes
Mucolipidosis II alpha/beta MIM#252500; Mucolipidosis III alpha/beta MIM#252600
Publications
Variants in this GENE are reported as part of current diagnostic practice
Phenotypes for gene: GNPTAB were changed from Mucolipidosis III alpha/beta 252600; Mucolipidosis II alpha/beta 252500 to GNPTAB-mucolipidosis MONDO:0100122; Mucolipidosis II alpha/beta, MIM# 252500; Mucolipidosis III alpha/beta, MIM# 252600
gene: GNPTAB was added gene: GNPTAB was added to Skeletal dysplasia. Sources: Emory Genetics Laboratory,Expert list,NHS GMS,Expert Review Green,Radboud University Medical Center, Nijmegen,UKGTN,Illumina TruGenome Clinical Sequencing Services Mode of inheritance for gene: GNPTAB was set to BIALLELIC, autosomal or pseudoautosomal Phenotypes for gene: GNPTAB were set to Mucolipidosis III alpha/beta 252600; Mucolipidosis II alpha/beta 252500